Peter, agree ... its amazing how negative the threads became on MCNS. Company is very solid, strong, credible and expansive content, outstanding balance sheet, growing client base, backlog and revenues, new technology upgrade, marketing blitz to begin soon, another acquisition to be announced shortly and profitability around the corner. With today's news, the street continues to take notice ... here the coverage profile:
ING Barings, Furman Selz: still maintaining coverage with BUY
BT Alex Brown: acquired by Deutsch Bank (spelling?) Wanted to move healthcare group from Baltimore to NY, most analysts left and went elsewhere, most notably CS First Boston.
CS First Boston: recruited analysts from BT Alex Brown, was expected to initiate coverage, and did so today (8/18) with a Strong Buy and target of $20.
Volpe Brown: The original analyst covering MCNS [Mark Mulcany] left and went to Pacific Growth; Mark?s boss, Ed Kierney re-initiated coverage with a Buy rating.
Pacific Growth: expect coverage to be initiated soon?
Warburg, Dillion Reed: also could initiate coverage soon?
Others: several other companies are evaluating MCNS
Ask yourself this question, does KOOP at 4X the valuation of MCNS have the same level of interest ... namely beyond its underwriters? Still very long and expecting good things. Regards. |
